SCAI shock classification in acute myocardial infarction: Insights from the National Cardiogenic Shock Initiative
Catheterization and Cardiovascular Interventions2020Vol. 96(6), pp. 1137–1142
Citations Over TimeTop 10% of 2020 papers
Ivan Hanson, Travis Tagami, Ramy Mando, Abdalla Kara Balla, Simon Dixon, Steven Timmis, Steven Almany, Srihari S. Naidu, David A. Baran, Alejandro Lemor, Sarah Gorgis, William W. O’Neill, Mir B. Basir, National Cardiogenic Shock Investigators
Abstract
In patients with AMI-CS enrolled in NCSI, SCAI Shock classification was reproducible, and predicted survival when applied at presentation and at 24 hr.
Related Papers
- → Use of the Impella 2.5 system alone, after and in combination with an intra-aortic balloon pump in patients with cardiogenic shock: case description and review of the literature(2012)20 cited
- → Successful Combined Use of Impella Recover 2.5 Device and Intra-Aortic Balloon Pump Support in Cardiogenic Shock from Acute Myocardial Infarction(2010)20 cited
- → 312: First North American Experience with Microaxial Percutaneous LVAD for Severe Cardiogenic Shock(2009)1 cited
- → TCT-647 Impella CP Use in Acute Myocardial Infarction Complicated by Cardiogenic Shock: A community Hospital Experience(2017)
- → TCT-589 Meta-analysis of Early Initiation of Impella in Acute Myocardial Infarction and Cardiogenic Shock(2017)